Viewing Study NCT01279850


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-29 @ 2:52 AM
Study NCT ID: NCT01279850
Status: COMPLETED
Last Update Posted: 2023-10-10
First Post: 2011-01-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuropathic Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lyrica View
None Regulatory Post Marketing Commitment Plan View
None Safety View
None Neuropathic Pain View
None Post Marketing Surveillance View